Literature DB >> 22525086

Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro.

Megan Cavanaugh Terp1, Finn Bauer, Yasuro Sugimoto, Bo Yu, Robert W Brueggemeier, L James Lee, Robert J Lee.   

Abstract

DOTAP, as a racemic mixture, is a cationic lipid and a widely used transfection reagent. In this study, the effect of DOTAP's stereochemical structure on transfection efficiency was evaluated in vitro. Racemic and enantiomerically pure DOTAP were used in lipoplex formulations to deliver siRNA to MCF-7 cells, targeting the aromatase enzyme. At the 50 nM siRNA concentration and lipid-to-RNA charge ratios of 4 and 5, the R enantiomer of DOTAP was found to perform better than either the S- or the racemic agent. In addition, at 10 nM siRNA concentration and a charge ratio of 3, the R- lipoplex formulation silenced aromatase by ∼50% whereas the S and racemic formulations caused no significant target downregulation. Differences in lipid packing were modeled using membrane simulations. The results showed that, when combined with cholesterol, pure R-DOTAP and S-DOTAP enantiomers had 105% and 115% of lipid density relative to racemic DOTAP, respectively. These findings suggest an important role of lipid chirality in future development of lipid based siRNA delivery systems.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525086      PMCID: PMC3504612          DOI: 10.1016/j.ijpharm.2012.04.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  20 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Use of horseradish peroxidase and fluorescent dextrans to study fluid pinocytosis in leukocytes.

Authors:  J M Oliver; R D Berlin; B H Davis
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

3.  Controlled environment vitrification system: an improved sample preparation technique.

Authors:  J R Bellare; H T Davis; L E Scriven; Y Talmon
Journal:  J Electron Microsc Tech       Date:  1988-09

Review 4.  DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.

Authors:  Dmitri Simberg; Sarah Weisman; Yeshayahu Talmon; Yechezkel Barenholz
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

5.  Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes.

Authors:  L Stamatatos; R Leventis; M J Zuckermann; J R Silvius
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

Review 6.  Estrogen receptors and human disease.

Authors:  Bonnie J Deroo; Kenneth S Korach
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

7.  7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.

Authors:  R W Brueggemeier; P K Li; C E Snider; M V Darby; N E Katlic
Journal:  Steroids       Date:  1987 Jul-Sep       Impact factor: 2.668

8.  Rapid cycling of lipid raft markers between the cell surface and Golgi complex.

Authors:  B J Nichols; A K Kenworthy; R S Polishchuk; R Lodge; T H Roberts; K Hirschberg; R D Phair; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

9.  Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells.

Authors:  C R Hopkins; I S Trowbridge
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

10.  Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains.

Authors:  P A Orlandi; P H Fishman
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  6 in total

1.  Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.

Authors:  Nirav Khatri; Dipesh Baradia; Imran Vhora; Mohan Rathi; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2014-08-22       Impact factor: 3.246

2.  Simplifying the Chemical Structure of Cationic Lipids for siRNA-Lipid Nanoparticles.

Authors:  Takeshi Kuboyama; Kaori Yagi; Tomoyuki Naoi; Tomohiro Era; Nobuhiro Yagi; Yoshisuke Nakasato; Hayato Yabuuchi; Saori Takahashi; Fumikazu Shinohara; Hiroto Iwai; Ayumi Koubara-Yamada; Kazumasa Hasegawa; Atsushi Miwa
Journal:  ACS Med Chem Lett       Date:  2019-04-12       Impact factor: 4.345

3.  Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts.

Authors:  Anu Puri; Faisal Ibrahim; André O'Reilly Beringhs; Camryn Isemann; Paul Zakrevsky; Abigail Whittenburg; Derek Hargrove; Tapan Kanai; Rebecca S Dillard; Natalia de Val; Michael H Nantz; Xiuling Lu; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2022-06-04       Impact factor: 6.096

Review 4.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

5.  Chiral cationic polyamines for chiral microcapsules and siRNA delivery.

Authors:  Justin Gharavi; Patrick Marks; Kelly Moran; Brett Kingsborough; Ruchi Verma; Yuan Chen; Ruitang Deng; Mindy Levine
Journal:  Bioorg Med Chem Lett       Date:  2013-08-26       Impact factor: 2.823

6.  Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA.

Authors:  Xinlong Zang; Huaiwei Ding; Xiufeng Zhao; Xiaowei Li; Zhouqi Du; Haiyang Hu; Mingxi Qiao; Dawei Chen; Yuihui Deng; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2016-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.